ClinicalTrials.Veeva

Menu

The Efficacy of Regional Scalp Block in Craniotomy

U

Universitas Airlangga

Status and phase

Completed
Early Phase 1

Conditions

Craniotomy Surgery
Scalp Nerve Block

Treatments

Procedure: nerve block with 0.5% ropivacaine
Drug: General anesthesia and opioids (fentanyl, propofol, rocuronium)

Study type

Interventional

Funder types

Other

Identifiers

NCT06720285
IRB: 0769/KEPK/IX/2023
INA-XOYLZRE (Registry Identifier)

Details and patient eligibility

About

The objective of this clinical trial is to evaluate the role of scalp nerve block in craniotomy. The primary questions it seeks to answer are: What are the efficacy and safety profiles of scalp nerve block in craniotomy? The anesthesia protocol and monitoring were standardized for all participants. Participants were divided into two groups: the scalp nerve block group and the general anesthesia group. General anesthesia was induced using fentanyl (1-2 mcg/kg), propofol (1-2 mg/kg), and rocuronium (0.6 mg/kg). In the scalp nerve block group, a nerve block was administered using 0.5% ropivacaine.

Enrollment

40 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged >18 years
  • American Society of Anesthesiologists (ASA) classification I-III
  • Glasgow Coma Scale (GCS) score ≥ 13
  • Elective craniotomy

Exclusion criteria

  • Patients with cardiovascular abnormalities, impaired renal and hepatic function, diabetes mellitus, systemic and/or scalp local infection, and those with a history of current dexamethasone administration

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Standard Treatment with Scalp Nerve Block
Experimental group
Description:
General anesthesia induction was performed by administering fentanyl 1-2 mcg/kg, propofol 1-2 mg/kg, and rocuronium 0.6 mg/kg. Subsequently, scalp nerve block was performed with 0.5% ropivacaine. During surgery, a sudden rise of heart rate and blood pressure higher than 20% from baseline was considered as pain, and a bolus of fentanyl was administered as rescue analgesia.
Treatment:
Drug: General anesthesia and opioids (fentanyl, propofol, rocuronium)
Procedure: nerve block with 0.5% ropivacaine
Standard Treatment
Active Comparator group
Description:
General anesthesia induction was performed by administering fentanyl 1-2 mcg/kg, propofol 1-2 mg/kg, and rocuronium 0.6 mg/kg. Then, continuous fentanyl infusion as analgesia maintenance as the standard treatment. During surgery, a sudden rise of heart rate and blood pressure higher than 20% from baseline was considered as pain, and a bolus of fentanyl was administered as rescue analgesia.
Treatment:
Drug: General anesthesia and opioids (fentanyl, propofol, rocuronium)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems